Literature DB >> 31286439

Relevance of solute carrier family 5 transporter defects to inherited and acquired human disease.

Miryam Cannizzaro1, Jana Jarošová1, Boel De Paepe2.   

Abstract

The solute carrier (SLC) group of membrane transport proteins is crucial for cells via their control of import and export of vital molecules across the cellular membrane. Defects in these transporters with narrow substrate specificities cause monogenic disorders, giving us essential clues of their precise roles in cellular functioning. The SLC5 family in particular has been linked to various human diseases, of mild and severe phenotype as well as high and low prevalence. In this review, we describe the effects on health of SLC5 dysfunction and dysregulation by summarizing findings in patients with transporter gene defects. Patients display a plethora of pathologies which include glucose/galactose malabsorption, familiar renal glycosuria, thyroid dyshormonogenesis, and distal hereditary motor neuronopathies. In addition, the therapeutic potential of intervening in transporter activities for treating common diseases such as diabetes and cancer is explored.

Entities:  

Keywords:  Cancer; Diabetes; Glucose/galactose malabsorption; Sodium glucose cotransporters; Solute carriers

Mesh:

Substances:

Year:  2019        PMID: 31286439     DOI: 10.1007/s13353-019-00502-1

Source DB:  PubMed          Journal:  J Appl Genet        ISSN: 1234-1983            Impact factor:   3.240


  73 in total

1.  Missense mutations in SGLT1 cause glucose-galactose malabsorption by trafficking defects.

Authors:  J T Lam; M G Martín; E Turk; B A Hirayama; N U Bosshard; B Steinmann; E M Wright
Journal:  Biochim Biophys Acta       Date:  1999-02-24

2.  A new severe mutation in the SLC5A7 gene related to congenital myasthenic syndrome type 20.

Authors:  J M Pardal-Fernández; M C Carrascosa-Romero; S Álvarez; M C Medina-Monzón; M Bengoa Caamaño; C de Cabo
Journal:  Neuromuscul Disord       Date:  2018-07-06       Impact factor: 4.296

3.  Bitterness of glucose/galactose: novel mutations in the SLC5A1 gene.

Authors:  Ben Pode-Shakked; Orit Reish; Cigdem Aktuglu-Zeybek; Dafna Kesselman; Benjamin Dekel; Yoram Bujanover; Yair Anikster
Journal:  J Pediatr Gastroenterol Nutr       Date:  2014-01       Impact factor: 2.839

Review 4.  Whole exome sequencing identification of novel candidate genes in patients with proliferative diabetic retinopathy.

Authors:  Cindy Ung; Angie V Sanchez; Lishuang Shen; Samaneh Davoudi; Tina Ahmadi; Daniel Navarro-Gomez; Ching J Chen; Heather Hancock; Alan Penman; Suzanne Hoadley; Mark Consugar; Carlos Restrepo; Vinay A Shah; Joseph F Arboleda-Velasquez; Lucia Sobrin; Xiaowu Gai; Leo A Kim
Journal:  Vision Res       Date:  2017-05-09       Impact factor: 1.886

5.  Iodide transporter NIS regulates cancer cell motility and invasiveness by interacting with the Rho guanine nucleotide exchange factor LARG.

Authors:  Claire Lacoste; Julie Hervé; Myriam Bou Nader; Alexandre Dos Santos; Nicolas Moniaux; Yannick Valogne; Rodrick Montjean; Olivier Dorseuil; Didier Samuel; Doris Cassio; Carla Portulano; Nancy Carrasco; Christian Bréchot; Jamila Faivre
Journal:  Cancer Res       Date:  2012-09-07       Impact factor: 12.701

Review 6.  Glucose transport families SLC5 and SLC50.

Authors:  Ernest M Wright
Journal:  Mol Aspects Med       Date:  2013 Apr-Jun

Review 7.  Sporadic inclusion-body myositis: A degenerative muscle disease associated with aging, impaired muscle protein homeostasis and abnormal mitophagy.

Authors:  Valerie Askanas; W King Engel; Anna Nogalska
Journal:  Biochim Biophys Acta       Date:  2014-09-18

8.  Cloning and functional characterization of human SMCT2 (SLC5A12) and expression pattern of the transporter in kidney.

Authors:  E Gopal; N S Umapathy; P M Martin; S Ananth; J P Gnana-Prakasam; H Becker; C A Wagner; V Ganapathy; P D Prasad
Journal:  Biochim Biophys Acta       Date:  2007-07-14

Review 9.  Autoimmune Aspects of Kawasaki Disease.

Authors:  Y Sakurai
Journal:  J Investig Allergol Clin Immunol       Date:  2018-09-05       Impact factor: 4.333

10.  Expression of the Na+/I- symporter (NIS) is markedly decreased or absent in gastric cancer and intestinal metaplastic mucosa of Barrett esophagus.

Authors:  Aron Altorjay; Orsolya Dohán; Anna Szilágyi; Monika Paroder; Irene L Wapnir; Nancy Carrasco
Journal:  BMC Cancer       Date:  2007-01-10       Impact factor: 4.430

View more
  6 in total

1.  SLC7A2 serves as a potential biomarker and therapeutic target for ovarian cancer.

Authors:  Tianshui Sun; Fangfang Bi; Zhuonan Liu; Qing Yang
Journal:  Aging (Albany NY)       Date:  2020-07-09       Impact factor: 5.682

2.  Identification of solute carrier family genes related to the prognosis and tumor-infiltrating immune cells of pancreatic ductal adenocarcinoma.

Authors:  Yuhua Meng; Yanting Li; Dalang Fang; Yuanlu Huang
Journal:  Ann Transl Med       Date:  2022-01

3.  Cell-based analysis of CLIC5A and SLC12A2 variants associated with hearing impairment in two African families.

Authors:  Samuel Mawuli Adadey; Edmond Wonkam-Tingang; Leonardo Alves de Souza Rios; Elvis Twumasi Aboagye; Kevin Esoh; Noluthando Manyisa; Carmen De Kock; Gordon A Awandare; Shaheen Mowla; Ambroise Wonkam
Journal:  Front Genet       Date:  2022-08-11       Impact factor: 4.772

4.  SLC7A1 Overexpression Is Involved in Energy Metabolism Reprogramming to Induce Tumor Progression in Epithelial Ovarian Cancer and Is Associated with Immune-Infiltrating Cells.

Authors:  Shijing You; Xiaoying Zhu; Yao Yang; XiuZhen Du; Kejuan Song; Qingmei Zheng; Pengjiao Zeng; Qin Yao
Journal:  J Oncol       Date:  2022-09-12       Impact factor: 4.501

5.  Myo-Inositol Transporter SLC5A3 Associates with Degenerative Changes and Inflammation in Sporadic Inclusion Body Myositis.

Authors:  Boel De Paepe; Caroline Merckx; Jana Jarošová; Miryam Cannizzaro; Jan L De Bleecker
Journal:  Biomolecules       Date:  2020-03-30

Review 6.  Sodium-coupled glucose transport, the SLC5 family, and therapeutically relevant inhibitors: from molecular discovery to clinical application.

Authors:  Gergely Gyimesi; Jonai Pujol-Giménez; Yoshikatsu Kanai; Matthias A Hediger
Journal:  Pflugers Arch       Date:  2020-08-07       Impact factor: 3.657

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.